These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19384597

  • 1. Histaminergic activity in a rodent model of Parkinson's disease.
    Nowak P, Noras L, Jochem J, Szkilnik R, Brus H, Körossy E, Drab J, Kostrzewa RM, Brus R.
    Neurotox Res; 2009 Apr; 15(3):246-51. PubMed ID: 19384597
    [Abstract] [Full Text] [Related]

  • 2. Ontogenetic serotoninergic lesioning alters histaminergic activity in rats in adulthood.
    Jośko J, Drab J, Jochem J, Nowak P, Szkilnik R, Korossy-Mruk E, Boroń D, Kostrzewa RM, Brus H, Brus R.
    Neurotox Res; 2011 Aug; 20(2):103-8. PubMed ID: 20838952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Machado-Filho JA, Correia AO, Montenegro AB, Nobre ME, Cerqueira GS, Neves KR, Naffah-Mazzacoratti Mda G, Cavalheiro EA, de Castro Brito GA, de Barros Viana GS.
    Behav Brain Res; 2014 May 01; 264():116-25. PubMed ID: 24525422
    [Abstract] [Full Text] [Related]

  • 7. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ, Chen Z, Liu FX, Hu DN, Luo JH.
    Neuropharmacology; 2007 Dec 01; 53(7):832-41. PubMed ID: 17919665
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine.
    Nowak P, Bojanek K, Szkilnik R, Jośko J, Boroń D, Adwent M, Gorczyca P, Kostrzewa RM, Brus R.
    Neurotox Res; 2011 May 01; 19(4):536-43. PubMed ID: 20369314
    [Abstract] [Full Text] [Related]

  • 10. Ontogenetic manganese exposure with perinatal 6-OHDA lesioning alters behavioral responses of rats to dopamine D₁ and D2 agonist treatments.
    Szkilnik R, Brus R, Malinowska-Borowska J, Nowak D, Waliczek M, Kostrzewa RM, Nowak P.
    Environ Toxicol Pharmacol; 2014 Jan 01; 37(1):28-36. PubMed ID: 24295730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats.
    Nowak P, Jochem J, Zwirska-Korczala K, Josko J, Noras L, Kostrzewa RM, Brus R.
    Neurotox Res; 2008 Apr 01; 13(2):79-83. PubMed ID: 18515210
    [Abstract] [Full Text] [Related]

  • 14. The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats.
    Czarnecka A, Konieczny J, Lenda T, Lorenc-Koci E.
    Brain Res; 2015 Nov 02; 1625():218-37. PubMed ID: 26319690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH, Liu J, Wang Y, Ali U, Wang T, Chen L.
    Chin J Physiol; 2011 Apr 30; 54(2):96-104. PubMed ID: 21789890
    [Abstract] [Full Text] [Related]

  • 18. Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats.
    Gregório ML, Wietzikoski EC, Ferro MM, Silveira JL, Vital MA, Da Cunha C.
    Neurotox Res; 2009 May 30; 15(4):359-66. PubMed ID: 19384569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA, Araujo DM, Hilt DC, Sheng J, Jiao S.
    Brain Res; 1997 Nov 28; 777(1-2):153-60. PubMed ID: 9449424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.